The Epidermal Growth Factor Receptor (EGFR) family of receptor tyrosine kinases (RTKs) is a major player in a variety of epithelial malignancies, such as breast cancer, non-small cell lung cancer, colorectal, gastric and ovarian cancer, and glioblastoma. This evidence concerns the gene EGFR and non-small cell lung carcinoma.